| Issue Date |
Title |
Author(s) |
| 2019 |
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 |
Lin, Yansong;Huang, Huiqiang;Guo, Ye;Chen, Libo;Bao, Jiandong;Chen, Ge;Chen, Libo;Cui, Yali;Ding, Yong;Guan, Haixia;Guo, Ye;Gao, Zairong;Huang, Huiqiang;Huang, Rui;Huang, Tao;Hou, Xiaorong;He, Xiayun;Li, Mei;Li, Shaohua;Li, Xiaoyi;Li, Xuena;Li, Yujun;Liang, Zhiyong;Luo, Yukun;Lin, Yansong;Lyu, Jing;Ma, Qingjie;Niu, Lijuan;Sun, Wenhai;Wang, Feng;Wang, Renfei;Wei, Feng;Xia, Yu;Yang, Aiming;Zhang, Bin;Zhang, Bo;Zhang, Guang;Zhang, Hong;Zhang, Li;Zheng, Xiangqian;An, Rui;Fang, Jugao;Fan, Youben;Gao, Ming;Guo, Zhuming;Huang, Gang;Ji, Qinghai;Jiang, Ningyi;Jiang, Yuxin;Kuang, Anren;Li, Fang;Li, Sijin;Li, Yaming;Liu, Shaoyan;Sun, Hui;Shan, Zhongyan;Tan, Jian;Tian, Wen;Wang, Jing;Wang, Tie;Xing, Xiaoping;Xu, Zhengang;Zhang, Fuquan;Zhao, Jiajun;Zhao, Yupei;Zhu, Jingqiang;Li, Hui;Li, Jiao;Li, Li;Zhang, Yingjie;Zhao, Teng |
| 2016 |
In Patients With Low- to Intermediate-Risk Thyroid Cancer, a Preablative Thyrotropin Level of 30 mu IU/mL Is Not Adequate to Achieve Better Response to I-131 Therapy |
Zhao, Teng;Liang, Jun;Guo, Zhenqing;Li, Tianjun;Lin, Yansong |
| Mar-2021 |
Inferior Vena Cava Tumor Thrombus From Thyroid Cancer Detected by Ga-68-PSMA-617 PET/CT |
Li, Hui;Liu, Yanqing;Zang, Jie;Yang, Zhi;Lin, Yansong |
| 2018 |
Is the ratio superior to the number of metastatic lymph nodes in addressing the response in patients with papillary thyroid cancer? |
Gao, Wen;Zhao, Teng;Liang, Jun;Lin, Yansong |
| 2016 |
Noninferior response in BRAF(V600E) mutant nonmetastatic papillary thyroid carcinoma to radioiodine therapy |
Li, Jiao;Liang, Jun;Zhao, Teng;Lin, Yansong |
| 2017 |
Overwhelming rapid metabolic and structural response to apatinib in radioiodine refractory differentiated thyroid cancer |
Lin, Yansong;Wang, Chen;Gao, Wen;Cui, Ruixue;Liang, Jun |
| 2016 |
Preablative Stimulated Thyroglobulin Correlates to New Therapy Response System in Differentiated Thyroid Cancer |
Yang, Xue;Liang, Jun;Li, Tianjun;Zhao, Teng;Lin, Yansong |
| 2019 |
Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy |
Liu, Jierui;Liu, Yanqing;Lin, Yansong;Liang, Jun |
| 2017 |
Serial stimulated thyroglobulin measurements are more specific for detecting distant metastatic differentiated thyroid cancer before radioiodine therapy |
Zhao, Teng;Liang, Jun;Li, Tianjun;Gao, Wen;Lin, Yansong |
| 2016 |
Serum thyrotropin level of 30 mu IU/mL is inadequate for preablative thyroglobulin to serve as a prognostic marker for differentiated thyroid cancer |
Zhao, Teng;Liang, Jun;Guo, Zhenqing;Li, Jiao;Lin, Yansong |
| 2017 |
TERT Promoter Mutation Predicts Radioiodine-Refractory Character in Distant Metastatic Differentiated Thyroid Cancer |
Yang, Xue;Li, Jiao;Li, Xiaoyi;Liang, Zhiyong;Gao, Wen;Liang, Jun;Cheng, Shujun;Lin, Yansong |
| 2016 |
Value of serial preablative thyroglobulin measurements: can we address the impact of thyroid remnants? |
Zhao, Teng;Liang, Jun;Li, Tianjun;Guo, Zhenqing;Vinjamuri, Sobhan;Lin, Yansong |
